Purpose: To investigate the effects of 2,3,5,4 -tetrahydroxystilbene-2-O-␤-D-glucoside (TSG) on the memory and movement functions and its mechanisms related to synapses and ␣-synuclein in aged mice. Methods: The memory ability of mice was detected by step-through passive avoidance task. The movement function was measured by the pole test and rotarod test. Transmission electron microscopy was used to observe the synaptic ultrastructure. Western blotting was applied to measure the expression of synapse-related proteins and ␣-synuclein. Results: Intragastrical administration of TSG for 3 months significantly improved the memory and movement functions in aged mice. TSG treatment obviously protected the synaptic ultrastructure and increased the number of synaptic connections in the hippocampal CA1 region and striatum; enhanced the expression of synaptophysin, phosphorylated synapsin I and postsynaptic density protein 95 (PSD95), elevated phosphorylated calcium/calmodulin-dependent protein kinase II (p-CaMKII) expression, and inhibited the overexpression and aggregation of ␣-synuclein in the hippocampus, striatum and cerebral cortex of aged mice. Conclusion: TSG improved the memory and movement functions in aged mice through protecting synapses and inhibiting ␣-synuclein overexpression and aggregation in multiple brain regions. The results suggest that TSG may be beneficial to the treatment of ageing-related neurodegenerative diseases.
Introduction
Aging population is the biggest challenge all over the world in the 21st century. Increased oxidative stress and misfolded protein formations, combined with impaired compensatory mechanisms, may promote aging (Cahill-Smith & Li, 2014; Godoy et al., 2014) and consequently lead to a high incidence of neurodegenerative diseases with ageing, such as Alzheimer's disease (AD), Parkinson's disease (PD) and dementia of Lewy body (DLB) (Jove et al., 2014) . Synaptic dysfunction plays an important role in the progression of cognitive impairment and movement disorder among these neurodegenerative diseases (Heutink & Verhage, 2012; Pienaar et al., 2012) . ␤-amyloid (A␤) is released at the synaptic terminals (Lazarov et al., 2002) and ␣-synuclein localizes in the synaptic vesicles (Bellucci et al., 2012; Iwai, 2000) where they can affect synaptic transmission. ␣-Synuclein is a highly abundant protein at the pre-synaptic terminals, and is associated with the distal reserve pool of synaptic vesicles and has a role in the regulation of neurotransmitter release, synaptic function and plasticity (Vargas et al., 2014) . Synaptic degeneration occurs early in the progression of AD involving neocortical and limbic system circuitries . Accumulating oligomeric ␣-synuclein may mediate early synaptic pathology in PD and DLB by disrupting synaptic vesicles (Rockenstein et al., 2014) .
Polygonum multiflorum has been widely used in China as an anti-aging agent since ancient times. 2,3,5, 4 -Tetrahydroxystilbene-2-O-␤-D-glucoside (TSG) is one of the main active component extracted from the root of Polygonum multiflorum. Our previous studies found that oral administration of TSG enhanced learning-memory ability and protected synaptic ultrastructure in the hippocampus of aged rats (Wang et al., 2007) . TSG also improved learning-memory impairment, decreased the content of A␤, and inhibited the overexpression and aggregation of ␣-synuclein in the hippocampus of APPV717I transgenic AD model mice (Zhang et al., 2006 . Since synaptic dysfunction and ␣-synuclein aggregation are common factors in the pathogenesis of neurodegenerative diseases, our discoveries about TSG evoked us to hypothesize that TSG might improve both memory and movement functions through protecting synapses and inhibiting ␣-synuclein aggregation in multiple brain regions.
Since aged animals have extensive degeneration in many brain regions, we chose 20-month-old mice as the animal model of ageing-related neurodegenerative diseases in the present study. In order to verify our hypothesis, we investigated the effects of TSG on memory and movement functions, synaptic ultrastructure, and the expression of synapse-related proteins (synaptophysin, synapsin I, and postsynaptic density protein 95), calcium/calmodulin-dependent protein kinase II (CaMKII) and ␣-synuclein in the hippocampus, striatum and cerebral cortex of aged mice.
Materials and methods

Drugs
2,3,5,4 -Tetrahydroxystilbene-2-O-␤-D-glucoside (TSG) used in this study was cross referenced to the previous description . We extracted TSG (molecular weight 406, C 20 H 22 O 9 ) from the root of Polygonum multiflorum according to a previously described protocol (Zhang et al., 2006) . TSG powder was dissolved in distilled water at the concentrations of 5, 10 and 20 mg/ml respectively and intragastrically administrated to the aged mice between 8 and 9 A.M. every day.
Animals and drug administration
Specific pathogen free C57BL/6J female mice were purchased from the Experimental Animal Center in Academy of Military Medical Sciences (Beijing, China). Animal housing and all experimental procedures followed the requirements of the Provisions and General Recommendations of Chinese Experimental Animal Administration Legislation. Animals were housed under a 12/12-h dark/light cycle and in standard pathogen-free conditions. They had free access to food and water throughout the entire experiment.
The 4-months-old mice were taken as the young control group (n = 20) while the 20-months-old mice were used as the aged model group (n = 20). The treatment groups of TSG at low dose (50 mg/kg), middle dose (100 mg/kg) and high dose (200 mg/kg) (n = 20 per group) were intragastrically given TSG once a day for 3 months (from the beginning of 18 to the end of 20 months of age). The young control and the aged model groups received an equal volume of distilled water every day. After behavioral tests, 6 mice per group were perfusion-fixed for preparing brain slices, and other mice were non-fixed for taking fresh brains.
Step-through test for memory ability evaluation
Step-through test, a kind of passive avoidance task, was used to measure the memory function of mice as described . The passive avoidance box was divided into two compartments, one illuminated and one dark, equipped with a grid floor. During the training trial, each mouse was placed in the lighted compartment; as soon as it entered the dark compartment, the door was closed and the mouse received an inescapable shock. The testing trial was conducted 24 h after the training trial. Mouse was again placed in the lighted compartment, the time before it entered the dark compartment was recorded as the latency, and the times of entering the dark compartment was counted as the error times.
Pole test for movement coordination detection
The pole test was performed according to the previous method (Hwang et al., 2005) . Briefly, mice were positioned with their heads upward near the top of a rough-surfaced wood pole (1 cm in diameter and 50 cm high). The time taken until they turned completely downward and arrived on the floor was recorded. The maximum time allowed was 120 s.
Rotarod test for movement function measurement
The rotarod test was conducted to assess the movement equilibrium function (Chen et al., 2013) . Mice were trained on a rotarod (YLS-4C type, Biological Research Apparatus, Shandong, China) at several different rod-rotation speeds. For testing, a 3 cm-diameter rotarod was set to rotate at 30 rpm. The duration from the time when the mouse was put on the rotarod until the mouse dropped off was recorded; the upper time limit was 180 s. All mice were tested three times, at 30-min intervals.
Electron microscopy for synaptic ultrastructure observation
Transmission electron microscopy (TEM) was used to detect synaptic ultrastructure according to a previous method (Wang et al., 2007) . After the behavioral tests, 10% chloral hydrate was intraperitoneally injected into mice (4 ml/kg). Under anesthesia, the chest was cut open. A fast injection of normal saline was given through a catheter placed in the left ventricle while the right auricle was cut open. When the liver turned light brown, 4% paraformaldehyde was infused until hardening of muscles and other tissues occurred. Coronary slices of the brain were prepared, and the tissue blocks (1 mm 3 ) were cut from the hippocampal CA1 region or the striatum. The tissues were put into 2% paraformaldehyde and 2.5% glutaraldehyde, then post-fixed by immersion in 2% osmium tetroxide and rotated for 30 min. The specimens were dehydrated by gradient alcohol from 50% to 100%. Then embedding reagent was used to replace the water within the tissue. After dehydration and embedment, semi-thin sections (1 m in thickness) were observed under a light microscope for trimming. Serial ultra-thin sections (50 nm in thickness) were prepared, stained with lead citrate and uranyl acetate, and observed under a transmission electron microscope (EM208s, Philips Co., Holland), then the photos at 50,000 times were taken. The number of synaptic connections was determined by calculating the postsynaptic density from 10 photos each section with Puncta Analyzer plug-in of ImageJ (MerchanPerez et al., 2009 ) by a person who was blinded to the animal grouping.
Western blot assay for protein expression measurement
Lysate preparation and western blotting were carried out as described . Equivalent amount of protein was separated on SDS-polyacrylamide gel (Bio-Rad) and transferred to polyvinylidene difluoride membrane. The membrane was incubated in 5% non-fat milk for 1 h in order to block nonspecific bindings and then changed into primary antibodies at the recommended dilutions overnight at 4 • C followed by the appropriate secondary antibody horseradish peroxidase-conjugated goat-anti-mouse or goat-anti-rabbit IgG (Santa cruz, USA). Primary antibodies against synaptophysin, pCaMKII (Cell signaling, USA), synapsin I, p-synapsin I (Santa cruz, USA), postsynaptic density protein 95 (PSD95) and ␣-synuclein (Abcam, USA) were used in this assay. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL system; Millipore, USA) and exposed to x-ray film (Kodak, Rochester, NY, USA).
Statistical analyses
Experimental values were expressed as mean ± standard error (SE). The differences among the groups were analyzed with one-way analysis of variance (ANOVA) with a Tukey post hoc test when comparing multiple groups. P values less than 0.05 were considered statistically significant. SPSS 11.5 and Microsoft Excel 2003 were used for the statistical tests.
Results
Effects of TSG on memory ability in aged mice
Step-through test was used to measure the passive avoidance memory ability of mice. Fig. 1 exhibited that the aged model mice at the age of 20 months had a shorter latency and more error times than young control mice at the age of 4 months (P < 0.01). Oral administration of TSG at the doses of 100 and 200 mg/kg for 3 months (from the beginning of 18 to the end of 20 months of age) increased the latency and decreased the error times compared with the aged model group (P < 0.05, P < 0.01), indicating that TSG improved the memory function in aged mice.
Effects of TSG on movement function in aged mice
Pole test was applied to detect movement coordination function of mice. The results showed that the aged model mice crawled down to the bottom with difficulty and spent longer time than the young control mice (P < 0.01). The mice treated with TSG at the doses of 50, 100 and 200 mg/kg spent shorter time to crawl down to the bottom compared with the aged model mice (P < 0.01; Fig. 2A ).
Rotarod test was used for the measurement of movement equilibrium function. The aged model mice stayed shorter time on the rotarod than the young control mice when the speed of rotation was 30 rpm (P < 0.01). TSG administration at the doses of 100 and Fig. 1 . Effects of TSG on memory ability in aged mice measured by step-through passive avoidance test. The 4-months-old mice were taken as the young control group, while the 20-months-old mice were used as aged model group. The treatment groups of 2,3,5,4 -tetrahydroxystilbene-2-O-␤-D-glucoside (TSG) at low dose (50 mg/kg), middle dose (100 mg/kg) and high dose (200 mg/kg) were intragastrically given TSG once a day for 3 months (from the beginning of 18 to the end of 20 months of age). (A) Mean latency before entering the dark compartment recorded 24 h after the training session. (B) Error times during the testing session. The data represent the mean ± standard error (SE), n = 18-20 mice per group. ## P < 0.01, aged model group vs. young control mice; * P < 0.05, * * P < 0.01, TSG groups vs. aged model mice. The data are from 10 photos each mouse, and expressed as mean ± SE; n = 3 mice per group. ## P < 0.01, aged model group vs. young control mice; * P < 0.05, * * P < 0.01, TSG groups vs. aged model mice.
200 mg/kg prolonged the time on the rotarod compared with the aged model group (P < 0.01; Fig. 2B ).
Effects of TSG on synaptic ultrastructure in hippocampus and striatum of aged mice
Synapses were defined by the presence of presynaptic and postsynaptic densities with immediately adjacent collections of synaptic vesicles irrespective of the size or the nature of subcellular organelles (Schmidt et al., 2008) . The pictures from transmission electron microscopy displayed the ultrastructure of synapses in the hippocampal CA1 region (Fig. 3A , B and C) and in the striatum (Fig. 3D , E and F) of different groups. In the young control mice, the fine structures of neuropils were clearly visible, the outline of synaptic membrane and synaptic cleft were clear, and a large amount of bright round vesicles distributed in the presynaptic terminals while the postsynaptic density was thick or long in the hippocampal CA1 region (Fig. 3A) and the striatum (Fig. 3D) . In the aged model mice, the outline of neuropils and synapses was indistinct and destructed, with decreased synaptic vesicles in the presynaptic terminals and thinner or shorter postsynaptic density ( Fig. 3B and E) . The treatment of TSG at the dose of 200 mg/kg restored the synaptic structures with clear outline, and increased synaptic vesicles and postsynaptic density in aged mice (Fig. 3 C and F) .
The results from quantitative analysis showed that the number of synaptic connections was much less in the hippocampal CA1 region (Fig. 3G ) and in the striatum (Fig. 3H ) of the aged model mice compared with the young control group (P < 0.01); and the treatment of TSG (50, 100 and 200 mg/kg) increased the number of synaptic connections in both brain regions of aged mice (P < 0.05, P < 0.01). Fig. 4 . Effects of TSG on synapse-related proteins in hippocampus, striatum and cerebral cortex of aged mice. Western blotting was used to detect the expression of synapse-related proteins. The representative bands of synaptophysin, phosphorylated synapsin, total synapsin I and postsynaptic density protein 95 (PSD95) in the hippocampus (A), cerebral cortex (B) and striatum (C) are displayed. The graphs represent the quantitative analyses of synaptophysin (D), the ratio of phosphorylated synapsin I/total synapsin I (E), and PSD95 (F) in three brain regions, respectively. Bands in each sample were normalized with ␤-actin density, and the value of young group was set as 100%. The data represent the mean ± SE; n = 3 mice per group. # P < 0.05, aged model group vs. young control mice; * P < 0.05, * * P < 0.01, TSG groups vs. aged model mice. . Bands in each sample were normalized with ␤-actin density, and the value of young group was set as 100%. The data are presented as the mean ± SE; n = 3 mice per group. # P < 0.05, aged model group vs. young control mice; * P < 0.05, * * P < 0.01, TSG groups vs. aged model mice.
Effects of TSG on synapse-related proteins in hippocampus, striatum and cerebral cortex of aged mice
The expression of synapse-related proteins in the hippocampus (Fig. 4A ), cerebral cortex (Fig. 4B) and striatum ( Fig. 4C ) was detected by western blotting. The quantitative analyses revealed that the expression of synaptophysin (a presynaptic protein) was lower in the hippocampus, cerebral cortex and striatum of aged model mice compared with the young control mice (P < 0.05); TSG treatment increased the expression of synaptophysin in the hippocampus and striatum of aged mice (P < 0.05; Fig. 4D ). The ratio of phosphorylated synapsin I/total synapsin I (a presynaptic protein) decreased in the hippocampus and cerebral cortex of aged model group (P < 0.05), and was elevated by TSG treatment (P < 0.01; Fig. 4E ). The level of PSD95 declined in the hippocampus and cerebral cortex in the aged model group (P < 0.05), and TSG administration enhanced the expression of PSD95 in the hippocampus, cerebral cortex and striatum of aged mice (P < 0.05, P < 0.01; Fig. 4F ).
Effects of TSG on phosphorylation of CaMKII in hippocampus, striatum and cerebral cortex of aged mice
CaMKII phosphorylation modulates PSD95 binding to NMDA receptors, and is related to the synaptic plasticity (Gardoni et al., 2006; Lee et al., 2009) . In the present experiment, the expression of phosphorylated CaMKII (p-CaMKII) was detected by using western blotting. Compared with the young control mice, p-CaMKII level decreased in the hippocampus, cerebral cortex and striatum of aged model group (P < 0.05). TSG treatment increased the level of p-CaMKII in these three brain regions of aged mice (P < 0.05, P < 0.01; Fig. 5 ), suggesting that TSG may have the potential to promote the synaptic plasticity.
Effects of TSG on α-synuclein in hippocampus, striatum and cerebral cortex of aged mice
Western blotting was used to detect the expression of ␣-synuclein in mouse brain. Fig. 6 displayed that the levels of the monomer, dimer and tetramer of ␣-synuclein increased in the hippocampus, cerebral cortex and striatum in the aged model mice compared with the young control group (P < 0.05, P < 0.01). TSG administration decreased the monomer, dimer and tetramer of ␣-synucle in the hippocampus, cerebral cortex and striatum of aged mice (P < 0.05, P < 0.01). The results indicated that TSG inhibited the overexpression and aggregation of ␣-synuclein in multiple brain regions of aged mice. , dimmer (C) and tetramer (D), respectively. Bands in each sample were normalized with ␤-actin density, and the value of young group was set as 100%. The data represent the mean ± SE; n = 3 mice per group. # P < 0.05, ## P < 0.01, aged model group vs. young control mice; * P <0.05, * * P < 0.01, TSG groups vs. aged model mice.
Discussion
The present study demonstrated that oral administration of TSG for 3 months improved the memory and movement functions, protected the synaptic ultrastructure and increased the synaptic connections, elevated the levels of synapse-related proteins and pCaMKII, and inhibited ␣-synuclein aggregation in the hippocampus, striatum and cerebral cortex of aged mice.
Aging may accelerate the degeneration of certain neurotransmitter systems such as acetylcholine or dopamine, resulting in cognitive impairment and movement disorder (Hattori et al., 2014) . Patients with PD often accompany with mild cognitive impairment and may develop to Parkinson disease dementia (PDD) (Connolly & Lang, 2014) . Dementia of Lewy body (DLB) share the similar pathological symptoms with PDD including cognitive impairment and spontaneous parkinsonism, as well as the presence of ␣-synucleincontaining Lewy bodies (Hanson & Lippa, 2009) . In this study, 20-month-old mice exhibited a decline in memory ability and motor coordination and equilibrium functions, the treatment of TSG improved these behavioral changes in aged mice, suggesting that TSG may be beneficial to ameliorating memory ability and movement functions in ageing-related neurodegenerative diseases.
Synaptic communications are important in the process of learning and memory (Sultana et al., 2010) . Despite accumulating evidence to conclusively suggest the former, with synapse loss having been observed precede neuron loss in early AD, further experimental work is called for to establish whether this phenomenon is also present in PD and in other neurodegenerative diseases to elucidate potential common mechanisms relevant to synaptic loss and neurodegeneration (Pienaar et al., 2012) . Synaptic vesicles in presynaptic terminals are key organelles to concentrate, store and release neurotransmitters into the synaptic cleft (Ahnert-Hilger et al., 2013) . The released neurotransmitter molecules interact with the postsynaptic receptors present in the postsynaptic density (Sultana et al., 2010) . In the present study, we found that TSG treatment protected the synaptic vesicles and increased the number of synaptic connections in the hippocampus and striatum of aged mice. These results suggest that synaptic protection may be one of the mechanisms by which TSG improved the memory and motor functions in aged mice.
Since many proteins are involved in the synaptic transmission, we further investigated the expression of synapse-related proteins. Synaptophysin is the most abundant synaptic vesicle protein, and plays an important role in the regulation of neurotransmitter release (Ahnert-Hilger et al., 2013) . The expression of synaptophysin responds to synaptic formation during embryonic development, making the protein a presynaptic marker for synaptic plasticity (Smith et al., 2000) . Synapsin I may be involved in regulating trafficking synaptic vesicles through phosphorylation dependent interactions with the synaptic vesicle membrane in presynaptic terminals, and phosphorylation of synapsin I mediates the formation of functional synapses and short-term synaptic plasticity (Yin et al., 2014) . PSD95 is involved in long-term potentiation (LTP), a key component of memory formation (Sultana et al., 2010) . It has been found that PSD95 is a substrate of CaMKII, while CaMKII regulates synaptic signaling maybe through phosphorylation of PSD95/SAP90 and glutamate receptors (Yoshimura et al., 2000) . In this study, we discovered that TSG treatment increased the levels of synaptophysin, phosphorylated synapsin I and PSD95 in the hippocampus, cerebral cortex and striatum in aged mice, which may be beneficial for protecting the synaptic structure and functions.
Calcium ion (Ca 2+ ) is an important second messenger that participates in the transmission of the depolarizing signal and contributes to synaptic activity (Cali et al., 2014) . Ca 2+ homeostasis may be disrupted during aging and neurodegenerative disease processes (Cali et al., 2014) . CaMKII phosphorylation modulates PSD95 binding to NMDA receptors, and is related to the synaptic plasticity (Gardoni et al., 2006; Lee et al., 2009 ). The reduction of phosphorylated CaMKII (p-CaMKII) at the synapses leads to memory impairment (Ly & Song, 2011) . Many reports indicate that CaMKII is involved in the pathogenesis and symptoms of a variety of mental and neurological diseases, such as learning disorder, cognitive impairment, AD and PD (Reese et al., 2011; Zhang et al., 2014) . In the present study, p-CaMKII decreased in several brain regions of aged mice, TSG treatment increased p-CaMKII in the hippocampus, striatum and cerebral cortex of aged mice, which may promote the synaptic plasticity and partly explain the mechanism of enhancing memory and movement functions.
␣-Synuclein is a 14 kDa synaptic protein involved in neurotransmitter release (Rockenstein et al., 2014) . PD and DLB are associated with abnormal aggregation of ␣-synuclein (Spinelli et al., 2014) . Pathological accumulation of ␣-synuclein occurs predominantly in neuronal cells and synapses in PD and DLB . A large body of evidence indicates that ␣-synuclein pathology at dopaminergic synapses may underlie the onset of neuronal dysfunction and degeneration in the PD brain (Bellucci et al., 2012) . Our present research revealed that TSG inhibited the overexpression and aggregation of ␣-synuclein in the hippocampus, striatum and cerebral cortex of aged mice, suggesting thatTSGmayhavethepotentialtotreatAD,Parkinson's disease dementia (PDD) and DLB.
In the present study, we focused on the synaptic mechanism of TSG on memory and motor functions. However, the complexity of neural circuits is also involved in memory and movement functions, therefore the present results could only partly explain the mechanisms of TSG's improving memory and motor functions, and further investigations on action mechanisms of TSG are still needed.
In conclusion, the present study demonstrated that TSG protected the synaptic ultrastructure, increased the number of synaptic connections, elevated the levels of synapse-related proteins (synaptophysin, phosphorylated synapsin I, and PSD95), enhanced phosphorylation of CaMKII, and inhibited ␣-synuclein overexpression and aggregation in the hippocampus, striatum and cerebral cortex of aged mice. These might be part of the mechanisms by which TSG improved the memory and movement functions of aged mice. The results suggest that TSG may be beneficial to the treatment of ageing-related neurodegenerative diseases.
